Log in or Sign up for Free to view tailored content for your specialty!
HIV/AIDS News
Precautions could have prevented HIV cases linked to ‘vampire facials’
DENVER — HIV infections linked to “vampire facials” performed at a spa in New Mexico could have been avoided if the now-closed spa had adhered to appropriate infection prevention and control practices, experts said.
Four children achieve treatment-free HIV remission for 1 year
DENVER — Four children born with HIV who initiated ART within 48 hours of delivery later remained in treatment-free remission for over a year after ART was paused, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Semaglutide can reduce severity of liver disease in people with HIV, study shows
DENVER — A low weekly dose of semaglutide can safely minimize what used to be called nonalcoholic fatty liver disease in people with HIV, a first-of-its-kind study found.
Injectable ART given every 8 weeks safely suppresses HIV in adolescents
DENVER — Long-acting injectable ART administered every 8 weeks safely suppresses HIV in adolescents, according to research presented at the Conference on Retroviruses and Opportunistic Infections.
Having access to long-acting option increased PrEP coverage in Ugandan study
DENVER — Giving patients the option of choosing long-acting PrEP resulted in a fivefold increase in coverage and a reduction in HIV incidence during the SEARCH trial in Uganda, researchers reported.
Investigational two-drug regimen safe, effective for patients with HIV
DENVER — Phase 2 study data showed that a once-weekly oral regimen of an investigational two-drug HIV treatment was well tolerated among patients with HIV and allowed them to maintain viral suppression.
VIDEO: IAS-USA endorses off-label use of long-acting ART for HIV
DENVER — The International Antiviral Society-USA (IAS-USA) has updated its HIV treatment guidelines to endorse the off-label use of long-acting injectable ART in patients with HIV viremia.
Study shows higher PrEP adherence among young women in Africa than previously reported
DENVER — New data from a cohort of adolescent and young women in sub-Saharan Africa showed a higher level of HIV PrEP adherence than has been reported in previous studies, researchers said.
VIDEO: Marrazzo reports promising PrEP data for cisgender women
DENVER — A new study provides reassurances that PrEP can reliably prevent HIV in cisgender women, even if they do not use it daily.
PrEP use up, HIV incidence down, data show
DENVER — Data from the United States and Australia show that PrEP uptake and adherence has increased, and the incidence of HIV has declined in recent years, researchers reported.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read